Clinical trial
Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
NCT01350869 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
- Lead sponsor
- Seung-Jung Park
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- June 30, 2014
- Enrollment
- 3,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.